Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism

Full text
Show less -
Lima Amato, Lorena Guimaraes [1] ; Montenegro, Luciana Ribeiro [1] ; Lerario, Antonio Marcondes [2, 1] ; Lima Jorge, Alexander Augusto [3] ; Guerra Junior, Gil [4] ; Schnoll, Caroline [1] ; Renck, Alessandra Covallero [1] ; Trarbach, Ericka Barbosa [3] ; Frade Costa, Elaine Maria [1] ; Mendonca, Berenice Bilharinho [1] ; Latronico, Ana Claudia [1] ; Gontijo Silveira, Leticia Ferreira [1, 5]
Total Authors: 12
[1] Univ Sao Paulo, Unidade Endocrinol Desenvolvimento, Lab Hormonios & Genet Mol LIM42, Disdplina Endocrinol & Metabol, Hosp Clin, Fac Med, Sao Paulo, SP - Brazil
[2] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 - USA
[3] Univ Sao Paulo, Unidade Endocrinol Genet LIM25, Disciplina Endocrinol & Metabol, Hosp Clin, Fac Med, Sao Paulo, SP - Brazil
[4] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Pediat, Campinas, SP - Brazil
[5] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG - Brazil
Total Affiliations: 5
Document type: Journal article
Source: EUROPEAN JOURNAL OF ENDOCRINOLOGY; v. 181, n. 2, p. 103-119, AUG 2019.
Web of Science Citations: 2

Context: Congenital hypogonadotropic hypogonadism (CHH) is a rare condition caused by GnRH deficiency. Several genes have been associated with the pathogenesis of CHH, but most cases still remain without a molecular diagnosis. The advent of next-generation sequencing (NGS) has allowed the simultaneous genotyping of several regions, faster, making possible the extension of the genetic knowledge of CHH. Objective: Genetic characterization of a large cohort of Brazilian CHH patients. Design and patients: A cohort of 130 unrelated patients (91 males, 39 females) with CHH (75 normosmic CHH, 55 Kallmann syndrome) was studied using a panel containing 36 CHH-associated genes. Results: Potential pathogenic or probably pathogenic variants were identified in 43 (33%) CHH patients. The genes ANOS1, FGFR1 and GNRHR were the most frequently affected. A novel homozygous splice site mutation was identified in the GNRH1 gene and a deletion of the entire coding sequence was identified in SOX10. Deleterious variants in the IGSF10 gene were identified in two patients with reversible normosmic CHH. Notably, 6.9% of the patients had rare variants in more than one gene. Rare variants were also identified in SPRY4, IL17RD, FGF17, IGSF1 and FLRT3 genes. Conclusions: This is a large study of the molecular genetics of CHH providing new genetic findings for this complex and heterogeneous genetic condition. NGS has been shown to be a fast, reliable and effective tool in the molecular diagnosis of congenital CHH and being able to targeting clinical genetic testing in the future. (AU)

FAPESP's process: 13/03236-5 - New approaches and methodologies in molecular-genetic studies of growth and pubertal development disorders
Grantee:Alexander Augusto de Lima Jorge
Support type: Research Projects - Thematic Grants